This multidimensional approach to glycemic management highlights their significance in treating type 2 diabetes. Figure 1 highlights the multifaceted effects of SGLT2 inhibitors on various organ systems, emphasizing their role in managing type 2 diabetes and potentially improving cardiovascular and renal health. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.